Lung and Esophageal Cancer Center Faculty / Medical Staff >

The Lung Esophageal Cancer Center is staffed by a team of board certified doctors from the departments of pulmonology, hematology and oncology, thoracic surgery, radiation oncology, radiology, pathology, and nuclear medicine, and exclusive coordinators. We apply cutting-edge technology and techniques to the treatment of cancer in order to improve diagnosis, testing, surgery, chemotherapy, and radiotherapy, and we follow exceptional treatment protocols by maintaining clear communication between departments. We are also developing and applying new treatment methods to provide rapid and appropriate treatment to patients, in order to embrace a leading role in treating lung and esophageal cancer.

Main Service

Specialties: lung cancer, esophageal cancer

Strengths

As a world-class hospital for the surgical treatment of lung cancer, our cancer center has shown exceptional surgical results.

  • Performed the most lung cancer surguriesin Korea in the last 10 years
  • Perform 1/3 of the esophageal cancer surgeries in Korea
  • Increased the percentage of minimally invasive thoracoscopic surgeries compared to more invasiveopen surgeries (58% thoracoscopic vs. 42% open in 2012).
  • Achieved the lowest postoperative prevalence and mortality rate, shortest hospitalization, and lowest surgical cost in Korea.
  • Embraces a multidisciplinary treatment practice in which professors from each department discuss appropriate treatment for 10-15 cases three times per week.

Diagnostic methods

Chest X-ray, Chest CT, sputum test, bronchoscopy, fine needle aspiration biopsy, positron emission tomography-computed tomography (PET-CT), bone scan, brain MRI, bronchoscopic ultrasound, mediastinoscopy

Latest treatment methods

Interventional bronchoscopy, surgery, chemotherapy, radiotherapy (3-dimensional conformal radiotherapy; 3DCRT), intensity modulated radiotherapy (IMRT) tomotherapy, body stereotactic radiotherapy (SBRT), proton therapy)

Recent trends in clinical research

Due to advances in molecular biology, “molecular targeted therapy,” which blocks a specific molecular pathways, has grown in popularity. Samsung Medical Center is currently performing studies on molecular targeted therapy in conjunction with other major hospitals to maximize treatment efficacy for inoperative lung cancer patients. However, since the first step of molecular targeted therapy is to conduct an analysis of cancer cell genes, molecular targeted therapy cannot be implemented without specific genetic testing. To accomplish this, the Lung Esophageal Cancer Center is conducting studies on targeted gene analysis using CancerSCANTM, a next-generation cancer genome diagnostic technology independently developed by the Samsung Genome Research Institute. This new technology can check for over 500 mutations in over 380 targeted genes in a single test (http://sgi.samsunghospital.com). This important advantage makes Samsung’s Lung Esophageal Cancer Center ideal for research regarding molecular targeted genes and the therapeutic agents derived from them. We are confident that this research will lead rapidly to new tools for the treatment of lung and esophageal cancer.

Other resources

In order to improve treatment results and contribute to patients' quality of life, we are developing, and adopting chemotherapy protocols that enhanced drug effectiveness while minimizing side effects. Our active participation in domestic and international clinical research gives our lung cancer patients the opportunity to benefit from the most up-to-date chemotherapy techniques, and we operate a daytime unit for our outpatients to minimize inconvenience they must experience during the standby period for chemotherapy.

Departments List
CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper medical and nursing services for their Health Protection and Promotion and they will not be discriminated for gender, age, religion, status, nationality, language, race, or physical/mental/financial circumstances nor be violated of their health. Medical team may not deny medical care without justifiable reason.

2. Right to be informed & autonomous decision

Patients have the right to receive be well-informed and to inquire in detail about the treating physician’s specialty, status of their disease, purpose of the treatment, treatment plan, method, expected results and side effects of the treatment, discharge plan, medical cost, whether or not they are a subject to medical research, organ transplant/donation and etc, and to decide whether to give consent. Patients may stop or deny specific treatment or planned medical care within the ethical guideline and may decide on an alternative treatment.

3. Right to have confidentiality

Patients will not be violated of their rights to confidentiality regarding their physical/health status and privacy. Medical team and facility may not reveal or announce patient’s confidential information, including personal information, unless patient has gives consent or specified in the law, such as criminal investigation.

4. Right to request for consultation and mediation

Patients may request for consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency) in the event of any medical dispute.

5. Right to be respected of values or beliefs

Patients will not be discriminated for their culture, religious values or beliefs, and their rights will not be violated.

6. Right to be physically protected and to have stability of mind and bod

Patients have the right to be protected from possible danger in the hospital and to have the stability of mind and body.

Patients’Responsibilities

1. Responsible to trust and respect the medical team

Patients must accurately inform the medical team of their health condition, trust and respect the medical team’s treatment plan. Patients may be responsible for consequences which results from not following the instruction.

2. Responsible to not use dishonest method for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest method, such as receiving medical case under disguised ownership.

3. Responsible to abide by all hospital regulations

Patients must abide by all hospital regulations, respect hospital staff and other patients, and earnestly fulfill the financial obligation to the hospital.